Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography

被引:60
作者
Greiner-Sosanko, Elizabeth [1 ]
Lower, Darla R. [1 ]
Virji, Mohamed A. [1 ]
Krasowski, Matthew D. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Dept Pathol, Div Clin Chem,Toxicol & Therapeut Drug Monitoring, Pittsburgh, PA 15260 USA
关键词
anticonvulsants; lamotrigine; zonisamide; carbamazepine; HPLC; UV detection;
D O I
10.1002/bmc.753
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance liquid chromatography assay with ultraviolet detection was developed for the simultaneous determination of the anti-epileptic drugs lamotrigine, carbamazepine and zonisamide in human plasma and serum. Lamotrigine, carbamazepine, zonisamide and the internal standard chloramphenicol were extracted from serum or plasma using liquid-liquid extraction under alkaline conditions into an organic solvent. The method was linear in the range 1-30 mu g/mL for lamotrigine, 220 mu g/mL for carbamazepine, and 1-40 mu g/mL for zonisamide. Within- and between-run precision studies demonstrated coefficient Of variation < 10% at all tested concentrations. Other anti-epileptic medications tested did not interfere with the assay. The method is appropriate for determining lamotrigine, carbamazepine and zonisamide serum or plasma concentrations for therapeutic monitoring. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:225 / 228
页数:4
相关论文
共 17 条
[1]   The pharmacokinetics and interactions of new antiepileptic drugs - An overview [J].
Bialer, M .
THERAPEUTIC DRUG MONITORING, 2005, 27 (06) :722-726
[2]   VALIDATION OF A RADIOIMMUNOASSAY FOR THE DETERMINATION OF HUMAN PLASMA-CONCENTRATIONS OF LAMOTRIGINE [J].
BIDDLECOMBE, RA ;
DEAN, KL ;
SMITH, CD ;
JEAL, SC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :691-694
[3]   Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy [J].
Contin, M ;
Balboni, M ;
Callegati, E ;
Candela, C ;
Albani, F ;
Riva, R ;
Baruzzi, A .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 828 (1-2) :113-117
[4]   Liquid chromatographic determination of plasma lamotrigine in pediatric samples [J].
Forssblad, E ;
Eriksson, AS ;
Beck, O .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (06) :755-758
[5]   LAMOTRIGINE ANALYSIS IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FRASER, AD ;
MACNEIL, W ;
ISNER, AF ;
CAMFIELD, PR .
THERAPEUTIC DRUG MONITORING, 1995, 17 (02) :174-178
[6]   Drug monitoring and toxicology: A procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV [J].
Juenke, JM ;
Brown, PI ;
Urry, FM ;
McMillin, GA .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2006, 30 (01) :27-30
[7]   The new antiepileptic drugs - Clinical applications [J].
LaRoche, SM ;
Helmers, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05) :615-620
[8]   The new antiepileptic drugs - Scientific review [J].
LaRoche, SM ;
Helmers, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05) :605-614
[9]   Optimized high-performance liquid chromatographic method for determination of lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide [J].
Lensmeyer, GL ;
Gidal, BE ;
Wiebe, DA .
THERAPEUTIC DRUG MONITORING, 1997, 19 (03) :292-300
[10]   High-performance liquid chromatographic assay of zonisamide in human plasma using a non-porous silica column [J].
Nakamura, M ;
Hirade, K ;
Sugiyama, T ;
Katagiri, Y .
JOURNAL OF CHROMATOGRAPHY B, 2001, 755 (1-2) :337-341